Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:30:31.697Z.
Calculation as of: 2026-10-06T13:30:31.697Z.
Quote observation: 2026-10-06T13:30:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2486b729cb124820e370a7041701f0c499bef64609729e12fa9331cc95375005
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-05-22.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$102.43M
EV/EBIT Ratio
57.35x
TTM Avg
89.36x
3Y Avg
94.92x
5Y Avg
1303.85x
Market Cap
$102.99M
EV/EBIT Ratio
0.63x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$107.58M
EV/EBIT Ratio
N/A
TTM Avg
56.93x
3Y Avg
94.02x
5Y Avg
53.96x
Market Cap
$108.94M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $99.01M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $99.24M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.43M | 57.35x | 89.36x | 94.92x | 1303.85x |
| Definitive Healthcare Corp. (DH)vs › | $102.99M | 0.63x | 0.59x | 0.59x | 0.59x |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.58M | N/A | 56.93x | 94.02x | 53.96x |
| Biomea Fusion, Inc. (BMEA)vs › | $92.54M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.94M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $91.68M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.33M | N/A | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $110.75M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2015-05-22 | 32.45x |
| 2015-05-21 | 32.45x |
| 2015-05-20 | 25.91x |
| 2015-05-19 | 22.64x |
| 2015-05-18 | 22.64x |
| 2015-05-15 | 22.64x |
| 2015-05-14 | 22.64x |
| 2015-05-13 | 19.37x |
| 2015-05-12 | 19.37x |
| 2015-05-11 | 22.64x |
| 2015-05-08 | 22.64x |
| 2015-05-07 | 25.91x |
| 2015-05-06 | 29.18x |
| 2015-05-05 | 22.64x |
| 2015-05-04 | 25.91x |
| 2015-05-01 | 29.18x |
| 2015-04-30 | 29.18x |
| 2015-04-29 | 32.45x |
| 2015-04-28 | 32.45x |
| 2015-04-27 | 29.18x |
| 2015-04-24 | 35.72x |
| 2015-04-23 | 35.72x |
| 2015-04-22 | 38.99x |
| 2015-04-21 | 38.99x |
| 2015-04-20 | 32.45x |
| 2015-04-17 | 35.72x |
| 2015-04-16 | 38.99x |
| 2015-04-15 | 32.45x |
| 2015-04-14 | 32.45x |
| 2015-04-13 | 38.99x |
| 2015-04-10 | 38.99x |
| 2015-04-09 | 35.72x |
| 2015-04-08 | 32.45x |
| 2015-04-07 | 35.72x |
| 2015-04-06 | 42.26x |
| 2015-04-02 | 42.26x |
| 2015-04-01 | 42.26x |
| 2015-03-31 | 32.45x |
| 2015-03-30 | 32.45x |
| 2015-03-27 | 32.45x |
| 2015-03-26 | 32.45x |
| 2015-03-25 | 35.72x |
| 2015-03-24 | 25.91x |
| 2015-03-23 | 29.18x |
| 2015-03-20 | 25.91x |
| 2015-03-19 | 16.11x |
| 2015-03-18 | 19.37x |
| 2015-03-17 | 16.11x |
| 2015-03-16 | 16.11x |
| 2015-03-13 | 16.11x |
| 2015-03-12 | 16.11x |
| 2015-03-11 | 12.84x |
| 2015-03-10 | 16.11x |
